Home
>
National Drug Code (NDC)
>
Azopt
Azopt - 0065-0275-15 - (brinzolamide)
Drug Information of Azopt
| Product NDC: | 0065-0275 |
| Proprietary Name: | Azopt |
| Non Proprietary Name: | brinzolamide |
| Active Ingredient(s): | 10 mg/mL & nbsp; brinzolamide |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Azopt
| Product NDC: | 0065-0275 |
| Labeler Name: | Alcon Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020816 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980430 |
Package Information of Azopt
| Package NDC: | 0065-0275-15 |
| Package Description: | 15 mL in 1 BOTTLE, PLASTIC (0065-0275-15) |
NDC Information of Azopt
| NDC Code | 0065-0275-15 |
| Proprietary Name | Azopt |
| Package Description | 15 mL in 1 BOTTLE, PLASTIC (0065-0275-15) |
| Product NDC | 0065-0275 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | brinzolamide |
| Dosage Form Name | SUSPENSION |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19980430 |
| Marketing Category Name | NDA |
| Labeler Name | Alcon Laboratories, Inc. |
| Substance Name | BRINZOLAMIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] |
